A detailed history of Gsa Capital Partners LLP transactions in Mannkind Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 15,342 shares of MNKD stock, worth $93,432. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,342
Previous 471,042 96.74%
Holding current value
$93,432
Previous $2.46 Million 96.06%
% of portfolio
0.01%
Previous 0.17%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$5.01 - $6.7 $2.28 Million - $3.05 Million
-455,700 Reduced 96.74%
15,342 $97,000
Q2 2024

Aug 15, 2024

SELL
$4.05 - $5.43 $625,190 - $838,218
-154,368 Reduced 24.68%
471,042 $2.46 Million
Q1 2024

May 03, 2024

BUY
$3.25 - $5.27 $405,886 - $658,159
124,888 Added 24.95%
625,410 $2.83 Million
Q4 2023

Feb 16, 2024

BUY
$3.34 - $4.29 $1.13 Million - $1.45 Million
337,494 Added 207.02%
500,522 $1.82 Million
Q3 2023

Nov 15, 2023

BUY
$3.91 - $5.45 $637,439 - $888,502
163,028 New
163,028 $673,000
Q1 2023

May 12, 2023

BUY
$3.95 - $5.63 $347,339 - $495,068
87,934 Added 205.18%
130,790 $536,000
Q4 2022

Feb 13, 2023

BUY
$3.02 - $5.37 $129,425 - $230,136
42,856 New
42,856 $226,000
Q2 2022

Aug 09, 2022

BUY
$2.67 - $4.77 $32,897 - $58,771
12,321 New
12,321 $47,000
Q4 2021

Feb 14, 2022

SELL
$4.05 - $5.37 $40,998 - $54,360
-10,123 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$3.89 - $5.48 $817,261 - $1.15 Million
-210,093 Reduced 95.4%
10,123 $44,000
Q2 2021

Aug 05, 2021

BUY
$3.61 - $5.45 $456,076 - $688,536
126,337 Added 134.57%
220,216 $1.2 Million
Q1 2021

May 10, 2021

BUY
$3.14 - $6.14 $243,393 - $475,935
77,514 Added 473.66%
93,879 $368,000
Q4 2020

Feb 03, 2021

SELL
$1.79 - $4.04 $160,654 - $362,594
-89,751 Reduced 84.58%
16,365 $51,000
Q3 2020

Nov 06, 2020

BUY
$1.56 - $2.08 $165,540 - $220,721
106,116 New
106,116 $199,000
Q3 2018

Nov 13, 2018

SELL
$1.01 - $2.19 $115,160 - $249,703
-114,020 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$1.59 - $2.38 $181,291 - $271,367
114,020 New
114,020 $217,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.